Your browser doesn't support javascript.
loading
Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization.
Clavero, Esther; Sanchez-Maldonado, José Manuel; Macauda, Angelica; Ter Horst, Rob; Sampaio-Marques, Belém; Jurczyszyn, Artur; Clay-Gilmour, Alyssa; Stein, Angelika; Hildebrandt, Michelle A T; Weinhold, Niels; Buda, Gabriele; García-Sanz, Ramón; Tomczak, Waldemar; Vogel, Ulla; Jerez, Andrés; Zawirska, Daria; Watek, Marzena; Hofmann, Jonathan N; Landi, Stefano; Spinelli, John J; Butrym, Aleksandra; Kumar, Abhishek; Martínez-López, Joaquín; Galimberti, Sara; Sarasquete, María Eugenia; Subocz, Edyta; Iskierka-Jazdzewska, Elzbieta; Giles, Graham G; Rybicka-Ramos, Malwina; Kruszewski, Marcin; Abildgaard, Niels; Verdejo, Francisco García; Sánchez Rovira, Pedro; da Silva Filho, Miguel Inacio; Kadar, Katalin; Razny, Malgorzata; Cozen, Wendy; Pelosini, Matteo; Jurado, Manuel; Bhatti, Parveen; Dudzinski, Marek; Druzd-Sitek, Agnieszka; Orciuolo, Enrico; Li, Yang; Norman, Aaron D; Zaucha, Jan Maciej; Reis, Rui Manuel; Markiewicz, Miroslaw; Rodríguez Sevilla, Juan José; Andersen, Vibeke.
Afiliação
  • Clavero E; Hematology Department, Virgen de las Nieves University Hospital, 18012 Granada, Spain.
  • Sanchez-Maldonado JM; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, PTS, 18016 Granada, Spain.
  • Macauda A; Instituto de Investigación Biosanataria IBs, Granada, 18014 Granada, Spain.
  • Ter Horst R; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • Sampaio-Marques B; Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.
  • Jurczyszyn A; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090 Vienna, Austria.
  • Clay-Gilmour A; Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4710-057 Braga, Portugal.
  • Stein A; Plasma Cell Dyscrasias Center, Department of Hematology, Jagiellonian University Medical College, 31-066 Kraków, Poland.
  • Hildebrandt MAT; Department of Biostatistics and Epidemiology, Arnold School of Public Health, University of South Carolina, Greenville, SC 29208, USA.
  • Weinhold N; Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55902, USA.
  • Buda G; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
  • García-Sanz R; Department of Lymphoma-Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Tomczak W; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
  • Vogel U; Department of Internal Medicine V, University of Heidelberg, 69120 Heidelberg, Germany.
  • Jerez A; Haematology Unit, Department of Clinical and Experimental Medicine, University of Pisa/AOUP, 56126 Pisa, Italy.
  • Zawirska D; Diagnostic Laboratory Unit in Hematology, University Hospital of Salamanca, IBSAL, CIBERONC, Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), 37007 Salamanca, Spain.
  • Watek M; Department of Hematooncology and Bone Marrow Transplantation, Medical University of Lublin, 20-059 Lublin, Poland.
  • Hofmann JN; National Research Centre for the Working Environment, DK-2100 Copenhagen, Denmark.
  • Landi S; Department of Hematology, Experimental Hematology Unit, Vall d'Hebron Institute of Oncology (VHIO), University Hospital Vall d'Hebron, 08035 Barcelona, Spain.
  • Spinelli JJ; Department of Hematology, University Hospital, 30-688 Kraków, Poland.
  • Butrym A; Holycross Medical Oncology Center, 25-735 Kielce, Poland.
  • Kumar A; Institute of Hematology and Transfusion Medicine, 00-791 Warsaw, Poland.
  • Martínez-López J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
  • Galimberti S; Department of Biology, University of Pisa, 56126 Pisa, Italy.
  • Sarasquete ME; Division of Population Oncology, BC Cancer, Vancouver, BC V5Z 4E6, Canada.
  • Subocz E; School of Population and Public Health, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
  • Iskierka-Jazdzewska E; Department of Cancer Prevention and Therapy, Wroclaw Medical University, 50-367 Wroclaw, Poland.
  • Giles GG; Alfred Sokolowski Specialist Hospital in Walbrzych Oncology Support Centre for Clinical Trials, 58-309 Walbrzych, Poland.
  • Rybicka-Ramos M; Institute of Bioinformatics, International Technology Park, Bangalore 560066, India.
  • Kruszewski M; Manipal Academy of Higher Education (MAHE), Manipal 576104, India.
  • Abildgaard N; Hospital 12 de Octubre, Complutense University, CNIO, CIBERONC, 28041 Madrid, Spain.
  • Verdejo FG; Haematology Unit, Department of Clinical and Experimental Medicine, University of Pisa/AOUP, 56126 Pisa, Italy.
  • Sánchez Rovira P; Diagnostic Laboratory Unit in Hematology, University Hospital of Salamanca, IBSAL, CIBERONC, Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), 37007 Salamanca, Spain.
  • da Silva Filho MI; Department of Hematology, Military Institute of Medicine, 04-141 Warsaw, Poland.
  • Kadar K; Department of Hematology, Medical University of Lodz, 90-419 Lodz, Poland.
  • Razny M; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC 3004, Australia.
  • Cozen W; Centre for Epidemiology and Biostatistics, School of Population and Global Health, The University of Melbourne, Melbourne, VIC 3010, Australia.
  • Pelosini M; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC 3168, Australia.
  • Jurado M; Department of Hematology, Specialist Hospital No. 1 in Bytom, Academy of Silesia, Faculty of Medicine, 40-055 Katowice, Poland.
  • Bhatti P; Department of Hematology, University Hospital No. 2, 85-168 Bydgoszcz, Poland.
  • Dudzinski M; Department of Hematology, Odense University Hospital, DK-5000 Odense, Denmark.
  • Druzd-Sitek A; Department of Medical Oncology, Complejo Hospitalario de Jaén, 23007 Jaén, Spain.
  • Orciuolo E; Department of Medical Oncology, Complejo Hospitalario de Jaén, 23007 Jaén, Spain.
  • Li Y; Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 580, D-69120 Heidelberg, Germany.
  • Norman AD; St Johns Hospital, 62769 Budapest, Hungary.
  • Zaucha JM; Department of Hematology, Rydygier Hospital, 31-826 Cracow, Poland.
  • Reis RM; Division of Hematology/Oncology, Department of Medicine, School of Medicine, Department of Pathology, School of Medicine, Susan and Henry Samueli College of Health Sciences, Chao Family Comprehensive Cancer Center, University of California at Irvine, Irvine, CA 92697, USA.
  • Markiewicz M; U.O. Dipartimento di Ematologia, Azienda USL Toscana Nord Ovest, 57124 Livorno, Italy.
  • Rodríguez Sevilla JJ; Hematology Department, Virgen de las Nieves University Hospital, 18012 Granada, Spain.
  • Andersen V; Instituto de Investigación Biosanataria IBs, Granada, 18014 Granada, Spain.
Int J Mol Sci ; 24(10)2023 May 09.
Article em En | MEDLINE | ID: mdl-37239846
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article